*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Effects of Sulforaphane in brain ischemic reperfusion injury in rats

Author: , MUNTADHER HAMEED THWAINI, AHMED R. ABU RAGHIF, NAJAH R.HADI
Abstract: Ischemic stroke is one of the major causes of mortality and disability worldwide. Limitation of cerebral blood flow due to thrombosis can cause ischemic stroke that in turn affect cellular homeostasis due to insufficient oxygen and nutrient supply. However re-establishment of cerebral blood flow can cause further deterioration of ischemic brain tissue by a series of inflammatory, apoptotic and oxidative events resulting in cerebral ischemic-reperfusion injury which in turn leads to neuronal cell death and neurological impairments. This study was carried out to evaluate the potential neuroprotective effects of sulforaphanein a global model of cerebral ischemic reperfusion injury in rats. A 24 Wistar-albino rats (weighing 200-300 grams) were divided randomly into 3 groups (n= 8 in each group), a sham (negative control) group, control (ischemic reperfusion group) and Sulforaphane group (5mg/kg) intraperitoneally. Rats were exposed to 30 minutes of ischemia followed by 1 hour of reperfusion. At the end of the reperfusion, rats were sacrificed and brain tissue samples were obtained for histopathological scoring and inflammatory markers measuring. Tissue levels of interleukin 1 beta (IL-1b), IL-6, IL-8, and tumour necrosis factor alpha (TNF-a) were significantly lower in Sulforaphane pre-treated group as compared to control group (p>0.05) in addition the histopathological score in Sulforaphane group were much lower than the control group. We concluded that administration of Sulforaphane can be useful preventive method in attenuating the degree of brain injury during ischemic reperfusion process as shown by a significant reduction of brain inflammatory markers and lower histopathological damage in comparison with control group.
Keyword: Sulforaphane, brain ischemic, rats
DOI: https://doi.org/10.31838/ijpr/2020.12.04.505
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free